mil 6 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
97
Structured Review
R&D Systems
mil 6
Mil 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1592 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mil+6/Mouse+IL-6+Quantikine+ELISA+Kit/pmc13126671-306-61-65
Average 97 stars, based on 1592 article reviews
Mil 6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1592 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mil+6/Mouse+IL-6+Quantikine+ELISA+Kit/pmc13126671-306-61-65
Average 97 stars, based on 1592 article reviews
mil 6 - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload. Article Snippet: .. XXXX, XXX, XXX−XXX L L929 (Sigma), human IL23 (1290-IL/CF, R&D Systems), cynomolgus IL12 (10215-CL, R&D systems), human neutrophil elastase (324681, Merck), human TNF-α (TNFA-HA4211, Acro Bioscience), Phytohemagglutinin-L (PHA) (11249738001, Sigma), QUANTI-Blue solution (rep-qbs, InvivoGen), tofacitinib (FT32555, Biosynth), WST-1 reagent (11644807001, Merck), Article Title: A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload Article Snippet: .. Actinomycin D (1229, R&D Systems), Healthy human PBMCs (Precision Medicine), HEK Blue Reporter Assay IL23 (hkb-il23, InvivoGen), HEK Blue Reporter Assay IL12 (hkb-il12, InvivoGen), L929 (Sigma), human IL23 (1290-IL/CF, R&D Systems), cynomolgus IL12 (10215-CL, R&D systems), human neutrophil elastase (324681, Merck), human TNF-α (TNFA-HA4211, Acro Bioscience), Phytohemagglutinin-L (PHA) (11249738001, Sigma), QUANTI-Blue solution (rep-qbs, InvivoGen), tofacitinib (FT32555, Biosynth), WST-1 reagent (11644807001, Merck), Article Title: NAG-1/GDF15 inhibits diabetic nephropathy via inhibiting AGE/RAGE-mediated inflammation signaling pathways in C57BL/6 mice and HK-2 cells. Article Snippet: Aims: Our previous studies showed that the nonsteroidal anti-inflammatory drug-activated gene-1, or growth differentiation factor-15 (NAG-1/GDF15) inhibits obesity and diabetes in mice.. The current study aimed to examine the role and molecular mechanisms of NAG-1/GDF15 in diabetic nephropathy (DN), which is largely unknown.. Main methods: Both male and female wild-type (Wt) C57BL/6 mice and mice overexpressing human NAG-1/ GDF15 (transgenic, Tg) were used, which were induced by high-fat diet (HFD)/streptozotocin (STZ) to establish the mouse model of DN. Article Title: IFI16/Ifi202 released from breast cancer induces secretion of inflammatory cytokines from macrophages and promotes tumor growth. Article Snippet: College of Pharmacy, Seoul National University, Seoul, South Korea Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea Cellus Inc., Daegu, South Korea Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, South Korea Cancer Research Institute, Seoul National University, Seoul, South Korea Bio‐MAX institute, Seoul National University, Seoul, South Korea Clinical Proteomics:Article Title: A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload Article Snippet: .. Actinomycin D (1229, R&D Systems), Healthy human PBMCs (Precision Medicine), HEK Blue Reporter Assay IL23 (hkb-il23, InvivoGen), HEK Blue Reporter Assay IL12 (hkb-il12, InvivoGen), L929 (Sigma), human IL23 (1290-IL/CF, R&D Systems), cynomolgus IL12 (10215-CL, R&D systems), human neutrophil elastase (324681, Merck), human TNF-α (TNFA-HA4211, Acro Bioscience), Phytohemagglutinin-L (PHA) (11249738001, Sigma), QUANTI-Blue solution (rep-qbs, InvivoGen), tofacitinib (FT32555, Biosynth), WST-1 reagent (11644807001, Merck), Reporter Assay:Article Title: A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload Article Snippet: .. Actinomycin D (1229, R&D Systems), Healthy human PBMCs (Precision Medicine), HEK Blue Reporter Assay IL23 (hkb-il23, InvivoGen), HEK Blue Reporter Assay IL12 (hkb-il12, InvivoGen), L929 (Sigma), human IL23 (1290-IL/CF, R&D Systems), cynomolgus IL12 (10215-CL, R&D systems), human neutrophil elastase (324681, Merck), human TNF-α (TNFA-HA4211, Acro Bioscience), Phytohemagglutinin-L (PHA) (11249738001, Sigma), QUANTI-Blue solution (rep-qbs, InvivoGen), tofacitinib (FT32555, Biosynth), WST-1 reagent (11644807001, Merck), Cell Culture:Article Title: KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. Article Snippet: MOLM-13 (RRID:CVCL_2119) was from DSMZ and cultured at 37 °C with 5% CO2 in RPMI 1640 medium supplemented with 10% FBS and penicillin (100 U mL−1)/streptomycin (0.1 mg mL−1). .. Mouse HSPCs and AML cells were cultured at 37 °C with 7.5% CO2 in BCM medium [45% IMDM + 45% DMEM + 10% FBS + 50 × 10−6 m β-mercaptoethanol + penicillin (100 U mL−1)/streptomycin (0.1 mg mL−1)] supplemented with 10% stem cell medium (SCM) including mIL-3 (10 ng mL−1, Cat# 403-ML; R&D Systems), Article Title: KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition Article Snippet: MOLM‐13 (RRID:CVCL_2119) was from DSMZ and cultured at 37 °C with 5% CO 2 in RPMI 1640 medium supplemented with 10% FBS and penicillin (100 U mL −1 )/streptomycin (0.1 mg mL −1 ). .. Mouse HSPCs and AML cells were cultured at 37 °C with 7.5% CO 2 in BCM medium [45% IMDM + 45% DMEM + 10% FBS + 50 × 10 −6 m β ‐mercaptoethanol + penicillin (100 U mL −1 )/streptomycin (0.1 mg mL −1 )] supplemented with 10% stem cell medium (SCM) including mIL‐3 (10 ng mL −1 , Cat# 403‐ML; R&D Systems), Article Title: Reinforced erythroid differentiation inhibits leukemogenic potential of t(8;21) leukemia Article Snippet: 1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 2Department of Hematology, Renmin Hospital of Wuhan University, Wuhan, China 3School of Life Sciences and Biotechnology, Shanghai JiaoTong University, Shanghai, China 4Collaborative Innovation Center of Hematology, Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, China shRNA:Article Title: KMT2D Deficiency Promotes Myeloid Leukemias which Is Vulnerable to Ribosome Biogenesis Inhibition. Article Snippet: MOLM-13 (RRID:CVCL_2119) was from DSMZ and cultured at 37 °C with 5% CO2 in RPMI 1640 medium supplemented with 10% FBS and penicillin (100 U mL−1)/streptomycin (0.1 mg mL−1). .. Mouse HSPCs and AML cells were cultured at 37 °C with 7.5% CO2 in BCM medium [45% IMDM + 45% DMEM + 10% FBS + 50 × 10−6 m β-mercaptoethanol + penicillin (100 U mL−1)/streptomycin (0.1 mg mL−1)] supplemented with 10% stem cell medium (SCM) including mIL-3 (10 ng mL−1, Cat# 403-ML; R&D Systems), Concentration Assay:Article Title: Reinforced erythroid differentiation inhibits leukemogenic potential of t(8;21) leukemia Article Snippet: 1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 2Department of Hematology, Renmin Hospital of Wuhan University, Wuhan, China 3School of Life Sciences and Biotechnology, Shanghai JiaoTong University, Shanghai, China 4Collaborative Innovation Center of Hematology, Ruijin Hospital Affiliated to Shanghai JiaoTong University School of Medicine, Shanghai, China |
